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Pneumonic plague, caused by the gram-negative bacteria Yersinia pestis, has led to millions of human casualties during several major pandemics and has the potential to be employed as a deadly biological warfare agent. For this reason, it is vital that an effective vaccine against Y. pestis be
created. Currently, a subunit vaccine exists which works by stimulating B-cells (humoral immunity), but it has failed to protect primates in aerosolized bacterial challenges. In an effort to complement the existing vaccine, an alternative vaccine strategy can use both B-cell stimulation and the targeting
of T cells (cell-mediated immunity) with an antigenic peptide isolated from the bacteria. To determine what proteins may stimulate T cells, bacteria from three different strains of Y. pestis, KIM 5, KIM 6, and KIM 8, were cultured on TBA plates for four days and then in BCS liquid medium at either 26
or 37°C for four hours. Subproteomic fractionation of different regions of Y. pestis cultures were obtained and examined using 2D-DIGE, size-spin filters, and mixed-mode chromatography to isolate protein fractions that may stimulate T cells. Once differential proteins are selected, future work
includes determining structure by mass spectrometry, and testing for antigenic peptides on T4 and T8 T cell stimulation assays.

Yersinia pestis
•Gram-negative bacteria (a)
•Lives in the stomach of fleas (b)
•Causative agent of plague.
•Most lethal pathogen in human history

(a)

Grow Bacteria
• Y. pestis cultured on TBA plate
for 4 days
• In BCS liquid culture for 4
hours at 26 or 37°C

(b)

•Three forms of infection:
•Bubonic
•Swelling of the lymph nodes
•Many epidemics throughout history (c)

•Septicemic

5-part Subproteomic
Fractionation
• Separate cell into 5
fractions

•Infection of the blood
(c)

Proteomic Results

Methods

•Pneumonic
•Infection of the lungs
•Can be passed person to person through the air

TCA Prep

Table 1. Summary of samples used.
• KIM 5- no pgm locus
• KIM 6- no pgm locus, no pCD1 plasmid
• KIM 8- no pgm locus, no pPCP plasmid

Two growing temperatures
• 26° C - flea body temperature
• 37° C - human body temperature

•
•
•
•
•

• Exchange sample buffer to
desired buffer
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• Determine protein
concentration

Charge

comparison of protein
expression
• Labeling with dye
• Electrophoresis (charge and
size separation)
• Image acquisition and analysis

Fig. 2. How 2D-DIGE works.
Adapted from: http://www.gelifesciences.com

• Mass Spectrometry to
determine structure
• T4 & T8 T cells assays for
vaccine development
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• Identify, Quantify, and
Purify proteins

Fig. 3. Diagram of mixed-mode
chromatography.

1.KIM5 26°C Peri
2. KIM5 37°C Peri
3.KIM6 26°C Peri
4. KIM6 37°C Peri
5.KIM5 26°C Sol Cy
6. KIM5 37°C Sol Cy
7.KIM6 26°C Sol Cy
8. KIM6 37°C Sol Cy
9.Mark

10.KIM5 26°C IM
11. KIM5 37°C IM
12.KIM6 26°C IM
13. KIM6 37°C IM
14.KIM5 26°C OM
15. KIM5 37°C OM
16.KIM6 26°C OM
17. KIM6 37°C OM

Fig.6. KIM5 at 26 and 37°C
Periplasm fractions separated by
size by size-spin filters.
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1.Mark
2.K526 large tube
3.K526 small tube
4.K526 >100K
5.K526 100-20K
6.K526 <20K

7.Mark
8.K537 large tube
9.K537 small tube
10.K537 >100K
11.K537 100-20K
12.K537 <20K

Discussion

Different banding patterns in gels indicate differences in protein expression between
the subcellular fractions, bacterial strains, or between temperatures. Confirmation of the
protein differences between the subcellular fractions is shown in Figure 4. Between the
bands that are circled notice how there are two bands at 37°C and only one band at 26°C in
the same position. This indicates there is a difference in Y. pestis expression of proteins when
the bacteria infects a host.
In Figure 5, the spots circled demonstrate periplasm proteins differentially expressed
between the strains. Table 2 gives a comparison of increased protein expression comparing
the strains. K537 and K626 appeared to be the most similar suggesting differences seen in
K837 correlate with absence of the pPCP plasmid. Proteins differentially expressed when this
plasmid is present suggest its crucial for up regulating proteins. These proteins will be
subject to further study. Figure 6 show the differential expression of KIM5 periplasm
proteins at 26 and 37°C. These proteins may be associated with virulence. These proteins
are promising for additional testing as antigenic peptides for vaccine development.

Future work

Mixed-Mode
Chromatography

Fig.4. KIM5 and KIM6 Subproteomic Fractions.

Table 2. Differential Protein Expression
Fig.5.
Number of
Periplasm
Comparison
Sample
Increased
fractions,
Expression Spots
2D-DIGE, pH
3-10.
2
Cy2 to Cy3 KIM537
Red spotsKIM626
15
K537.Blue
42
Cy5 to Cy3 KIM837
spotsKIM626
45
K626.Green Cy2 to Cy5 KIM537
42
spots -K837.
KIM837
26
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Collect proteins

3 4

Fig.1. Schematic of cell fractions
of Y. pestis. An ultracentrifuge is
able to separate these layers for
protein collection and testing.
Type III Secretion System (T3SS) is
an example of a pathogenic
mechanism by which bacteria
infect host cells.

Protein Assay

2D-DIGE:

2

Secretome (Sec)
Outer membrane (OM)
Periplasm (Peri)
Inner membrane (IM)
Soluble cytosolic (Sol Cy)

Size

•Catalog proteins and better understand pathogenicity in this
organism
•Detect specific proteins associated with virulence
•Determine proteins that elicit T cell activity using different
proteomic samples

1

Five protein fractions of gram-negative bacteria

•Need to develop a safe and effective vaccine

(d)

Inner mem. Outer mem.

Three Strains of Y. pestis

•Potential bioterrorism agent
•Ineffective vaccines
•Killed, whole cell do not offer adequate protection
•Live attenuated vaccine not licensed for human use (3).
•Subunit vaccine targeting B-cells, humoral immunity, has
been ineffective in primate aerosol challenges (1).
•New approach: make a vaccine that targets T-cells, cellmediated immunity, in combination with the B-cell vaccine
(2). (d)
•How? Proteomics- The collection of proteins an organism is
expressing at any given time.

Periplasm Cytosolic

Periplasmic fraction has been shown to elicit a response in T-cells
Further proteomic characterization research will be continued
 Additional samples will be sent to the Trudeau Institute for T cell testing
Antigenic peptides will be determined to help develop a vaccine
Vaccine including T cell epitopes will be tested to prevent Y. pestis infections
Add vaccine to United States arsenal against bioterrorism

